Menu
Currency
GWAS Study

Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.

Swaminathan B, Thorleifsson G, Jöud M et al.

26007630 PubMed ID
GWAS Study Type
227446 Participants
73 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SB
Swaminathan B
TG
Thorleifsson G
JM
Jöud M
AM
Ali M
JE
Johnsson E
AR
Ajore R
SP
Sulem P
HB
Halvarsson BM
EG
Eyjolfsson G
HV
Haraldsdottir V
HC
Hultman C
IE
Ingelsson E
KS
Kristinsson SY
KA
Kähler AK
LS
Lenhoff S
MG
Masson G
MU
Mellqvist UH
MR
Månsson R
NS
Nelander S
OI
Olafsson I
SO
Sigurðardottir O
SH
Steingrimsdóttir H
VA
Vangsted A
VU
Vogel U
WA
Waage A
NH
Nahi H
GD
Gudbjartsson DF
RT
Rafnar T
TI
Turesson I
GU
Gullberg U
SK
Stefánsson K
HM
Hansson M
TU
Thorsteinsdóttir U
NB
Nilsson B
Chapter II

Abstract

Summary of the research findings

Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells. While first-degree relatives of patients with MM show an increased risk of MM, the genetic basis of inherited MM susceptibility is incompletely understood. Here we report a genome-wide association study in the Nordic region identifying a novel MM risk locus at ELL2 (rs56219066T; odds ratio (OR)=1.25; P=9.6 × 10(-10)). This gene encodes a stoichiometrically limiting component of the super-elongation complex that drives secretory-specific immunoglobulin mRNA production and transcriptional regulation in plasma cells. We find that the MM risk allele harbours a Thr298Ala missense variant in an ELL2 domain required for transcription elongation. Consistent with a hypomorphic effect, we find that the MM risk allele also associates with reduced levels of immunoglobulin A (IgA) and G (IgG) in healthy subjects (P=8.6 × 10(-9) and P=6.4 × 10(-3), respectively) and, potentially, with an increased risk of bacterial meningitis (OR=1.30; P=0.0024).

2,194 European ancestry cases, 222,555 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

227446
Total Participants
GWAS
Study Type
Yes
Replicated
586 European ancestry cases, 2,111 European ancestry controls
Replication Participants
European
Ancestry
Sweden, Denmark, Iceland, Norway
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.